Phitonex, Inc., developers of next generation fluorescent labels for biomarker detection, is pushing the envelope of what is possible in flow cytometry and today publicly shared the first data set showing 40 colors measured simultaneously on single cells in an experiment.
| DURHAM, N.C., April 14, 2020 /PRNewswire/ -- Phitonex, Inc., developers of next generation fluorescent labels for biomarker detection, is pushing the envelope of what is possible in flow cytometry and today publicly shared the first data set showing 40 colors measured simultaneously on single cells in an experiment. Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8714451-phitonex-immunology-research-40-color-flow-cytometry/ In life science research and diagnostics, the number of questions per individual cell is the key determining factor in the clinical efficacy of a life-saving treatment, the potential for a new cure, or the diagnostic ability of a new test. These questions are dictated by the available fluorescent labels for detection, which have been far outpaced by current flow cytometry instrumentation. Building on a backbone panel of 34 fluorescent-tagged antibodies, Phitonex incorporated six of its NovaFluor labels to ask 40 simultaneous questions per single cell. This enables broader and deeper immune cell profiling than ever before. Notably, the tunability and clarity of NovaFluor labels brings deeper insight without the cost of more complicated experimental design or data analysis. “It is incredibly exciting to show that NovaFluor labels immediately unlock a higher number of parameters on current instrumentation and provide unmatched cell population resolution. By utilizing these labels, we are able to achieve a remarkable increase in the resolution of cell populations and break through the false asymptote that current dye performance engenders.” Seddon Thomas, Ph.D. Research Application Scientist, said. Phitonex NovaFluor fluorescent labels delivered this new level of inquiry with:
“We have pushed flow cytometry to the upper limit of what is currently possible, and the timing is critical as we work with our customers and partners in the fight against diseases including COVID-19, where understanding the immune response is critical” said Michael Stadnisky, Ph.D, CEO of Phitonex. Phitonex has released its NovaFluor CD4 test kits; pre-orders for its Conjugation Kits, which begin shipping within the month; and is taking orders for custom conjugated antibodies. Phitonex plans to release more labels for high resolution biology soon. For more information about their labels and to connect to discuss your application, please visit www.phitonex.com or email info [at] phitonex.com. About Phitonex, Inc. Phitonex, Inc. is a developer of next generation fluorescent labels for biomarker detection. These labels establish a new paradigm in the detection of biological molecules on single cells, critically important in the development of new treatments and cures as the single cell is the fundamental unit of health and disease. NovaFluor reagents are available for purchase at www.phitonex.com. NovaFluor and Phitonex are registered trademarks of Phitonex, Inc. Labels are for research use only, not for use in diagnostic procedures.
SOURCE Phitonex, Inc. |
View original content:
